Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237770 · ClinicalTrials.gov registry record · Phase 2
Prevention of Low Blood Pressure in Persons With Tetraplegia
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00237770 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 16 participants.
The verdict
NCT00237770, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The aim of this investigation is to determine the blood pressure response to NOS inhibition, with L-NAME, in persons with tetraplegia compared to non-SCI control subjects and to establish if blood pressure can be increased while upright in those with tetraplegia. If blood pressure is increased with NOS inhibition in persons with tetraplegia, this would improve our treatment of the condition of low blood pressure during seated postures in individuals with tetraplegia.
Interventions
- DRUG N-Nitro L-arginine-methylester (L-NAME)
- PROCEDURE Head-up Tilt maneuver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00237770
The ClinicalTrials.gov registry entry for NCT00237770 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which N-Nitro L-arginine-methylester (L-NAME) is the first listed.
NCT00237770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00237770 about?
NCT00237770 is a clinical study titled "Prevention of Low Blood Pressure in Persons With Tetraplegia". The aim of this investigation is to determine the blood pressure response to NOS inhibition, with L-NAME, in persons with tetraplegia compared to non-SCI control subjects and to establish if blood pressure can be increased while upright in those with tetraplegia. If blood pressure is increased with ...
What is the current status of trial NCT00237770?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2003-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00237770?
The interventions under investigation include: N-Nitro L-arginine-methylester (L-NAME) (DRUG), Head-up Tilt maneuver (PROCEDURE).
Who is sponsoring clinical trial NCT00237770?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.